Friday, May 30, 2025
6:30 PM – 8:00 PM CT
Please note this virtually live meeting is at: 7:30 PM Eastern; 6:30 PM Central; 5:30 PM Mountain; 4:30 PM Pacific
FACULTY
 |
Bradley J. Monk, MD, FACS, FACOG Medical Director Late-Phase Clinical Research Florida Cancer Specialists and Research Institute West Palm Beach, FL |
PROGRAM OVERVIEW
The goal of this program is to increase the health care professional’s ability to: analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors; identify potential adverse events associated with HER2-targeted antibody-drug conjugates and evaluate the need to accurately assess HER2 status in HER2-expressing solid tumors to facilitate use of HER2-targeted antibody-drug conjugates when appropriate.
TARGET AUDIENCE
This activity is intended for US-based community oncology teams, including oncologists and multidisciplinary healthcare providers involved in the treatment of patients with HER2-positive solid tumors including gynecological, bladder, and biliary tract cancers.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors
- Identify potential adverse events associated with HER2-targeted antibody-drug conjugates
- Evaluate the need to accurately assess HER2 status in HER2-expressing solid tumors to facilitate use of HER2-targeted antibody-drug conjugates when appropriate
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this virtually live activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
